Cannell & Co. Abbott Laboratories Transaction History

Cannell & Co.

$3.01 Billion
Q4 2023

A detailed history of Cannell & Co. transactions in Abbott Laboratories stock. As of the latest transaction made, Cannell & Co. holds 347,795 shares of ABT stock, worth $44.1 Million. This represents 1.27% of its overall portfolio holdings.

Number of Shares

347,795

Previous 342,822 1.45%

Holding current value

$44.1 Million

Previous $33.2 Million 15.3%

% of portfolio

1.27%

Previous 1.17%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 05, 2024	BUY	$90.19 - $110.4 $448,514 - $549,019	4,973 Added 1.45%	347,795 $38.3 Million
Q3 2023 Nov 14, 2023	BUY	$95.53 - $114.62 $843,338 - $1.01 Million	8,828 Added 2.64%	342,822 $33.2 Million
Q2 2023 Aug 09, 2023	BUY	$100.78 - $112.29 $428,818 - $477,793	4,255 Added 1.29%	333,994 $36.4 Million
Q1 2023 May 08, 2023	SELL	$96.86 - $114.01 $259,294 - $305,204	-2,677 Reduced 0.81%	329,739 $33.4 Million
Q4 2022 Feb 03, 2023	BUY	$95.06 - $111.52 $256,947 - $301,438	2,703 Added 0.82%	332,416 $36.5 Million
Q3 2022 Nov 02, 2022	BUY	$96.76 - $112.03 $86,793 - $100,490	897 Added 0.27%	329,713 $31.9 Million
Q2 2022 Aug 08, 2022	SELL	$102.07 - $123.37 $1.06 Million - $1.28 Million	-10,350 Reduced 3.05%	328,816 $35.7 Million
Q1 2022 May 10, 2022	SELL	$114.02 - $139.04 $552,426 - $673,648	-4,845 Reduced 1.41%	339,166 $40.1 Million
Q4 2021 Feb 09, 2022	SELL	$115.53 - $141.46 $2.24 Million - $2.75 Million	-19,428 Reduced 5.35%	344,011 $48.4 Million
Q3 2021 Nov 10, 2021	SELL	$116.66 - $129.06 $2.02 Million - $2.23 Million	-17,305 Reduced 4.55%	363,439 $42.9 Million
Q2 2021 Aug 09, 2021	SELL	$105.79 - $124.53 $15.5 Million - $18.2 Million	-146,192 Reduced 27.74%	380,744 $44.1 Million
Q1 2021 May 07, 2021	SELL	$108.84 - $128.23 $87,942 - $103,609	-808 Reduced 0.15%	526,936 $63.1 Million
Q4 2020 Feb 11, 2021	SELL	$105.0 - $114.42 $679,770 - $740,755	-6,474 Reduced 1.21%	527,744 $57.8 Million
Q3 2020 Nov 12, 2020	SELL	$91.64 - $111.29 $695,547 - $844,691	-7,590 Reduced 1.4%	534,218 $58.1 Million
Q2 2020 Aug 07, 2020	SELL	$76.57 - $98.0 $1.63 Million - $2.08 Million	-21,240 Reduced 3.77%	541,808 $49.5 Million
Q1 2020 May 05, 2020	SELL	$62.82 - $91.86 $310,959 - $454,707	-4,950 Reduced 0.87%	563,048 $44.4 Million
Q4 2019 Feb 10, 2020	BUY	$78.51 - $87.4 $190,386 - $211,945	2,425 Added 0.43%	567,998 $49.3 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $1.12 Million - $1.21 Million	-13,667 Reduced 2.36%	565,573 $47.3 Million
Q2 2019 Aug 12, 2019	SELL	$72.88 - $85.0 $2.29 Million - $2.67 Million	-31,457 Reduced 5.15%	579,240 $48.7 Million
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $1.65 Million - $2 Million	-24,987 Reduced 3.93%	610,697 $48.8 Million
Q4 2018 Feb 11, 2019	SELL	$65.56 - $74.27 $2.6 Million - $2.94 Million	-39,614 Reduced 5.87%	635,684 $46 Million
Q3 2018 Nov 05, 2018	SELL	$60.81 - $73.36 $941,277 - $1.14 Million	-15,479 Reduced 2.24%	675,298 $49.5 Million
Q2 2018 Aug 06, 2018	SELL	$57.57 - $63.54 $7.14 Million - $7.88 Million	-123,996 Reduced 15.22%	690,777 $42.1 Million
Q1 2018 May 09, 2018	SELL	$56.27 - $63.62 $11.9 Million - $13.5 Million	-212,255 Reduced 20.67%	814,773 $48.8 Million
Q4 2017 Feb 13, 2018	SELL	$53.68 - $57.47 $1.95 Million - $2.08 Million	-36,265 Reduced 3.41%	1,027,028 $58.6 Million
Q3 2017 Nov 08, 2017	BUY	$48.06 - $53.64 $51.1 Million - $57 Million	1,063,293	1,063,293 $56.7 Million

Others Institutions Holding ABT

# of Institutions

3,378

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.72M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $222B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannell & Co., based on Form 13F filings with the SEC.

News

Stay updated on Cannell & Co. with notifications on news.

Account